Buy Ospolot Online

(Sulthiame)

The active ingredient in Ospolot is sulthiame. Sulthiame is an anticonvulsant and a carbonic anhydrase inhibitor. Its exact anticonvulsant action is not fully described, but it helps control certain seizure types in epilepsy.

Follow all directions given to you by your doctor and read all documents provided, including the full Prescribing Information, FDA-Approved Product Labeling, Instructions for Use, and Medication Guide, before using Ospolot. However, the following is a synopsis of the general guidelines for the use of Ospolot:

• Take Ospolot exactly as prescribed by your healthcare professional.
• Ospolot tablets should preferably be swallowed whole with a little fluid after meals.
• Treatment usually starts at a low dose and is increased gradually until your response is satisfactory.
• Finding the right dose may take about 4 weeks.

Some mild or common side effects of Ospolot include:

• Loss of appetite and weight loss.
• Dizziness.
• Double vision.
• Headache.
• Nausea.
• Vomiting.
• Drowsiness.

Some individuals may experience serious side effects while using Ospolot. These side effects may require immediate medical attention. If you experience any of the following, contact your healthcare provider or seek emergency medical help:

• Suicidal thoughts, self-harm thoughts, new or worsening depression, or unusual mood or behaviour changes.
• Stevens-Johnson syndrome or serious skin reaction, including severe skin rash, blistering, or peeling.
• Severe allergic reaction. Signs may include shortness of breath, skin rash, or swelling of the lips or tongue.
• Worsening seizures, grand-mal status, or increased seizure activity.
• Metabolic acidosis, which may include fast breathing, tiredness, confusion, or vomiting.
• Severe drowsiness, weakness, slurred speech, or coma-like symptoms.
• Kidney problems, including acute renal failure or kidney stones. Signs may include lower back pain and painful or difficult urination.
• Liver problems or increased liver enzymes. Signs may include yellowing of the skin or eyes and upper right quadrant pain.

These are not all of the possible side effects of Ospolot. You should always seek medical advice from your healthcare provider for any questions or concerns about your medical condition or treatment. Read all patient information, medication guides, or drug information sheets that come with this medication. You can also report adverse effects to the Food and Drug Administration at www.fda.gov/medwatch or 1-800-FDA-1088.

Before starting Ospolot, it is crucial to discuss any existing health conditions with your healthcare provider. You should be sure that your healthcare provider is aware of all your medical conditions, including:

A history of psychiatric disorders.

Impaired kidney function.

Known hypersensitivity or allergy to sulthiame, other sulfonamides, or any inactive ingredients such as magnesium stearate or titanium dioxide.

Known acute porphyria.

Hyperthyroidism.

Arterial hypertension.

Ospolot treatment is started at a low dose and increased until the clinical response is satisfactory. This may take about 4 weeks.

When Ospolot is taken with other prescription drugs, over-the-counter medications, vitamins, and supplements, it may change how they work or increase the frequency or severity of side effects. Make sure that you tell your healthcare professional about anything that you are taking to avoid any negative drug interactions, including:

• Alcohol - must not be consumed during treatment because it may cause a disulfiram-like reaction with symptoms such as headache, nausea, vomiting, low blood pressure, confusion, shock reactions, loss of consciousness, or seizures.
• Primidone - may cause severe side effects, especially in children, including dizziness, unstable gait, drowsiness, and psychotic reactions.
• Phenytoin - sulthiame may increase phenytoin blood levels, so strict monitoring and possible dose changes may be needed.
• Phenobarbitone - sulthiame may increase phenobarbitone blood levels.
• Carbamazepine - may decrease sulthiame blood levels.
• Lamotrigine - lamotrigine blood levels may increase in some cases, so closer monitoring may be needed when starting treatment.
• Other carbonic anhydrase inhibitors, such as topiramate or acetazolamide - may increase side effects related to carbonic anhydrase inhibition.

Ospolot is available as film-coated tablets containing 50 mg or 200 mg of sulthiame.

It should be stored at room temperature, out of the reach of children and pets.

Ospolot is supplied by Phebra Pty Ltd.

No, there is no generic equivalent.

Do not stop taking Ospolot unless your doctor tells you to. Stopping an anticonvulsant suddenly may increase seizure risk. Your healthcare provider can advise you on how to reduce or stop treatment safely.

Ospolot is Pregnancy Category D in Australia. This means it has caused, is suspected to have caused, or may be expected to cause an increased risk of human fetal malformations or irreversible damage. If Ospolot is used during pregnancy, the dose should be kept as low as possible, especially between days 20 and 40 of gestation.

Talk to your doctor if you are already pregnant or if you have any plans to become pregnant. They will know or recommend what is best for you.

It is not known whether sulthiame passes into breast milk or whether it may harm a newborn. Ospolot is not recommended for breastfeeding mothers unless the expected benefit outweighs any potential risk.

Talk to your doctor if you are already breastfeeding or if you have any plans to breastfeed. They will know or recommend what is best for you.